191 related articles for article (PubMed ID: 1577271)
1. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.
Kretzschmar M; Meisterernst M; Scheidereit C; Li G; Roeder RG
Genes Dev; 1992 May; 6(5):761-74. PubMed ID: 1577271
[TBL] [Abstract][Full Text] [Related]
2. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Fujita T; Nolan GP; Ghosh S; Baltimore D
Genes Dev; 1992 May; 6(5):775-87. PubMed ID: 1577272
[TBL] [Abstract][Full Text] [Related]
3. Differential transcriptional activation in vitro by NF-kappa B/Rel proteins.
Lin R; Gewert D; Hiscott J
J Biol Chem; 1995 Feb; 270(7):3123-31. PubMed ID: 7852394
[TBL] [Abstract][Full Text] [Related]
4. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
5. NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I.
Montano MA; Kripke K; Norina CD; Achacoso P; Herzenberg LA; Roy AL; Nolan GP
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12376-81. PubMed ID: 8901589
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of human polyomavirus JC: evidence for a functional interaction between RelA (p65) and the Y-box-binding protein, YB-1.
Raj GV; Safak M; MacDonald GH; Khalili K
J Virol; 1996 Sep; 70(9):5944-53. PubMed ID: 8709216
[TBL] [Abstract][Full Text] [Related]
7. The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.
Morin PJ; Gilmore TD
Nucleic Acids Res; 1992 May; 20(10):2453-8. PubMed ID: 1598203
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta.
Liu H; Sidiropoulos P; Song G; Pagliari LJ; Birrer MJ; Stein B; Anrather J; Pope RM
J Immunol; 2000 Apr; 164(8):4277-85. PubMed ID: 10754326
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro.
Pazin MJ; Sheridan PL; Cannon K; Cao Z; Keck JG; Kadonaga JT; Jones KA
Genes Dev; 1996 Jan; 10(1):37-49. PubMed ID: 8557193
[TBL] [Abstract][Full Text] [Related]
10. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
11. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.
Read MA; Whitley MZ; Williams AJ; Collins T
J Exp Med; 1994 Feb; 179(2):503-12. PubMed ID: 7507507
[TBL] [Abstract][Full Text] [Related]
12. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
13. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
14. Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3).
Duckett CS; Perkins ND; Kowalik TF; Schmid RM; Huang ES; Baldwin AS; Nabel GJ
Mol Cell Biol; 1993 Mar; 13(3):1315-22. PubMed ID: 8441377
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
16. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation.
Ten RM; Paya CV; Israël N; Le Bail O; Mattei MG; Virelizier JL; Kourilsky P; Israël A
EMBO J; 1992 Jan; 11(1):195-203. PubMed ID: 1740105
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.
Yurochko AD; Kowalik TF; Huong SM; Huang ES
J Virol; 1995 Sep; 69(9):5391-400. PubMed ID: 7636984
[TBL] [Abstract][Full Text] [Related]
18. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription.
Kundu M; Guermah M; Roeder RG; Amini S; Khalili K
J Biol Chem; 1997 Nov; 272(47):29468-74. PubMed ID: 9368006
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG.
He B; Weber GF
Biochem Biophys Res Commun; 2004 Aug; 321(1):13-20. PubMed ID: 15358208
[TBL] [Abstract][Full Text] [Related]
20. Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
Torgerson TR; Colosia AD; Donahue JP; Lin YZ; Hawiger J
J Immunol; 1998 Dec; 161(11):6084-92. PubMed ID: 9834092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
